TherapeuticsMD (TXMD) Prices 26M Share Common Offering at $2.75/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Pre-Open 10/24: (TSLA) (AYR) (PYPL) Higher (ACOR) (TWTR) (TXMD) Lower (more...)
October 24, 2019 9:20 AM EDTToday's Pre-Open Movers
Acorda Therapeutics, Inc. (NASDAQ: ACOR) 18.7% LOWER; JPMorgan downgraded from Neutral to Underweight.
Tesla (NASDAQ: TSLA) 18.2% HIGHER; reported Q3 EPS of $1.86, $2.28 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $6.3 billion versus the consensus estimate of $6.33 billion.
Twitter (NYSE: TWTR) 17.1% LOWER; reported Q3 EPS of $0.17, $0.03 worse than the analyst estimate of $0.20. Revenue for the quarter came in at $824 million versus the consensus estimate... More
After-Hours Movers 10/23: (TSLA) (MKSI) (PYPL) Higher; (TXMD) (NTGR) (EBAY) Lower (more...)
October 23, 2019 5:50 PM EDTToday's After-Hours Movers
Tesla (NASDAQ: TSLA) 18.2% HIGHER; reported Q3 EPS of $1.86, $2.28 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $6.3 billion versus the consensus estimate of $6.33 billion.
TherapeuticsMD, Inc. (NASDAQ: TXMD) 16% LOWER; announced the launch of an underwritten public offering of 22,000,000 shares of its common stock. TherapeuticsMD also expects to grant the underwriters of the offering a 30-day option to purchase up to an additional 3,300,000 shares of common... More
TherapeuticsMD (TXMD) Announces Proposed Underwritten Public Offering of 22 Million Shares of Common
October 23, 2019 5:05 PM EDTTherapeuticsMD, Inc. (NASDAQ: TXMD) today announced the launch of an underwritten public offering of 22,000,000 shares of its common stock. TherapeuticsMD also expects to grant the underwriters of the offering a 30-day option to purchase up to an additional 3,300,000 shares of common stock at the public offering price, less the underwriting discount.... More
